Cns Pharmaceuticals, Inc. (CNSP) — S-1 Filings
All S-1 filings from Cns Pharmaceuticals, Inc.. Browse 3 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (3)
-
CNS Pharmaceuticals Files S-1 with SEC
— Apr 14, 2025 Risk: medium
CNS Pharmaceuticals, Inc. filed an S-1 registration statement with the SEC on April 14, 2025. The company, incorporated in Nevada, is in the pharmaceutical prep -
CNS Pharmaceuticals Files S-1 for Public Offering
— Jul 12, 2024 Risk: medium
CNS Pharmaceuticals, Inc. filed an S-1 registration statement on July 12, 2024, indicating plans to offer securities. The company, incorporated in Nevada with p -
CNS Pharmaceuticals Files S-1 for Future Offering
— Jun 10, 2024 Risk: medium
CNS Pharmaceuticals, Inc. filed an S-1 registration statement on June 7, 2024, for an unspecified offering. The company, incorporated in Nevada with its princip
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX